Optima Pharmaceuticals Al-Isra'a
Optima Pharmaceuticals Al-Isra'a, commonly referred to as Al-Isra'a, is a prominent player in the pharmaceutical industry, headquartered in Egypt (EG). Established in 2005, the company has made significant strides in the development and distribution of high-quality pharmaceutical products across the Middle East and North Africa. Specialising in a diverse range of therapeutic areas, Al-Isra'a is known for its innovative formulations and commitment to quality, which set it apart in a competitive market. The company’s core offerings include prescription medications, over-the-counter products, and specialised healthcare solutions, all designed to meet the evolving needs of patients and healthcare providers. With a strong market presence and a reputation for excellence, Optima Pharmaceuticals Al-Isra'a continues to achieve notable milestones, reinforcing its position as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Optima Pharmaceuticals Al-Isra'a's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Optima Pharmaceuticals Al-Isra'a's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Optima Pharmaceuticals Al-Isra'a's reported carbon emissions
Optima Pharmaceuticals Al-Isra'a, headquartered in Egypt (EG), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of publicly available information may reflect a broader industry context where many pharmaceutical companies are increasingly focusing on sustainability and carbon reduction initiatives. For stakeholders and environmentally conscious consumers, it is crucial to monitor Optima Pharmaceuticals Al-Isra'a's future commitments and actions towards climate responsibility, as the pharmaceutical sector continues to evolve in its approach to environmental sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Optima Pharmaceuticals Al-Isra'a is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
